|
|
Interactions of rifampicin derivatives with pregnane X receptor and OATP1B1 transporter
Krajníková, Zdeňka ; Smutný, Tomáš (advisor) ; Mladěnka, Přemysl (referee)
Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Pharmacology and Toxicology Student: Zdeňka Krajníková Supervisor: PharmDr. Tomáš Smutný, Ph.D. Title of diploma thesis: Interactions of rifampicin derivatives with pregnane X receptor and OATP1B1 transporter Pregnane X receptor (PXR) is a ligand-activated transcription factor, which regulates gene expression in the liver. Among PXR target genes, cytochrome P450 3A4 (CYP3A4) is the most important enzyme responsible for metabolism of clinically used drugs. Rifampicin (RIF) is a prototype PXR ligand. It enters hepatocytes across the basolateral membrane by OATP1B1 transporter. Noteworthy, RIF is a chemically unstable molecule. Additionally, it is also metabolized in the human body. In this diploma thesis, we decided to determine the affinity of RIF derivatives (i.e. rifampicin quinone, rifampicin N-oxide, 25-desacetylrifampicin, and 3-formylrifamycin SV) to PXR and OATP1B1, which has not been explored in details so far. For this, two hybrid and gene reporter assays were employed. As revealed by two hybrid assay, rifampicin quinone, rifampicin N-oxide, and 3- formylrifamycin SV (10 µM) activated PXR at a level comparable with RIF (positive control). Contrary, 25-desacetylrifampicin showed a lower affinity to PXR than that...
|
|
|
Interactions of rifampicin derivatives with pregnane X receptor and OATP1B1 transporter
Krajníková, Zdeňka ; Smutný, Tomáš (advisor) ; Mladěnka, Přemysl (referee)
Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Pharmacology and Toxicology Student: Zdeňka Krajníková Supervisor: PharmDr. Tomáš Smutný, Ph.D. Title of diploma thesis: Interactions of rifampicin derivatives with pregnane X receptor and OATP1B1 transporter Pregnane X receptor (PXR) is a ligand-activated transcription factor, which regulates gene expression in the liver. Among PXR target genes, cytochrome P450 3A4 (CYP3A4) is the most important enzyme responsible for metabolism of clinically used drugs. Rifampicin (RIF) is a prototype PXR ligand. It enters hepatocytes across the basolateral membrane by OATP1B1 transporter. Noteworthy, RIF is a chemically unstable molecule. Additionally, it is also metabolized in the human body. In this diploma thesis, we decided to determine the affinity of RIF derivatives (i.e. rifampicin quinone, rifampicin N-oxide, 25-desacetylrifampicin, and 3-formylrifamycin SV) to PXR and OATP1B1, which has not been explored in details so far. For this, two hybrid and gene reporter assays were employed. As revealed by two hybrid assay, rifampicin quinone, rifampicin N-oxide, and 3- formylrifamycin SV (10 µM) activated PXR at a level comparable with RIF (positive control). Contrary, 25-desacetylrifampicin showed a lower affinity to PXR than that...
|
|
|
Fish collagen foam properties optimalization for medical and veterinary use.
Lukáč, Peter ; Grus, Tomáš (advisor) ; Rohn, Vilém (referee) ; Matia, Ivan (referee)
V průběhu projektu byly vyvinuty unikátní kolagenní pěny z kolagenu získaného z kůže sladkovodní ryby (kapr obecný, Cyprinus carpio). Pomocí síťování karbodiimidem byl překonán problém s nestabilitou kolagenní matrix z kolagenu získávaného z chladnokrevných živočichů při tělesné teplotě savců. Následně byly pěny impregnovány antibiotiky (gentamicin a vankomycin) a opětovně lyofilizovány, což je postup, který zajišťuje požadovanou koncentraci antibiotika bez rizika následného vymytí při dalších technologických krocích. Uvedený produkt je, na rozdíl od přípravků z nesíťovanéhokolagenu, stabilní i při sterilizaci gamma zářením. Finální sterilizovaný produkt byl testován in vivo na potkaním modelu infikované rány. Byla prokázána efektivita v léčbě potenciálně letální infekce Pseudomonas aeruginosa a kmene Stafylococcus aureus rezistentní k meticilinu (MRSA). Vzhledem k vysoké potřebě profylaxe a terapie infekcí pooperačních a jiných ran právě výše uvedenými polyrezistentními původci se jedná o slibný prostředek k budoucímu klinickému využití. Zkušenosti, které jsme získali v průběhu uvolnování ATB z kolagenních pěn budou v dalším vyvoji použity pro impregnaci zevní kolagenní vrstvy cévní protézy, čímž bychom mohli eliminovat jednu z největších nevýhod a rizik spojených s použitím umělých materiálu a tím je...
|
|
| |
|
|
Formulation and characterization of oxims loaded PLGA nanoparticles
Hafezi, Ramin ; Šnejdrová, Eva (advisor) ; Paraskevopoulos, Georgios (referee)
Thesis title: Formulation and characterization of oxime loaded PLGA nanoparticles Author: Ramin Hafezi Supervisor: PharmDr. Eva Šnejdrová, Ph.D. Advisor: PharmDr. Juraj Martiška, Ph.D. Department: Department of Pharmaceutical Technology The diploma thesis was focused on PLGA nanoparticles (NPs) which could be loaded with oximes, prepared by a double emulsion technique, and characterised by size, polydispersity and zeta potential. The theoretical part deals with the most common methods of the NPs preparation, the polymers and stabilizers employed, and drug delivery to brain. In the experimental part the effect of various formulation factors on NP characteristics were studied: linear or branched PLGA derivative, the concentrations of polymer, the volumes of primary emulsion. Dichloromethane (DCM) or Dimethyl sulfoxide (DMSO) as solvent for polymers were used and Poloxamer 407 or Didodecyldimethylammonium bromide (DDAB) as an outer phase stabilizer were employed. By comparison among the collected results, it seemed 1% A2 in DMSO and stabilization with poloxamer 407 could be best candidate for the oxime loaded drug delivery systems as it was possible to produce nanoparticles with size from 152 to 168 nm with PDI of below 0.15. Electrostatic stability in case of using DDAB was resulted excellent and...
|
guest ::
